Sleep apnoea, sleepiness, inflammation and insulin resistance in middle-aged males and females

European Respiratory Journal

Volumn 43, Issue 1, 2014, Pages 145-155

  Kritikou, Ilia ^a   Basta, Maria ^a,b   Vgontzas, Alexandros N ^a   Pejovic, Slobodanka ^a   Liao, Duanping ^a   Tsaoussoglou, Marina ^c   Bixler, Edward O ^a   Stefanakis, Zacharias ^b   Chrousos, George P ^c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CRETE   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; INSULIN; INTERLEUKIN 6; LEPTIN; PLACEBO; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; CONTROLLED STUDY; DISEASE ASSOCIATION; EMOTIONAL STRESS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POSITIVE END EXPIRATORY PRESSURE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REVIEW; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; SOMNOLENCE; THERAPY EFFECT; TREATMENT DURATION;

ADIPONECTIN; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; CROSS-OVER STUDIES; FEMALE; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; LEPTIN; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SEX FACTORS; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84891912546     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00126712     Document Type: Review

References (46)

1. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: A long-term follow-up. Eur Respir J 2006; 28: 596-602.
2. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997; 82: 1313-1316.
3. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: Relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000; 85: 1151-1158.
4. Vgontzas AN, Zoumakis E, Bixler EO, et al. Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest 2008; 38: 585-595.
5. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002; 105: 2462-2464.
6. Minoguchi K, Yokoe T, Tazaki T, et al. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 2005; 172: 625-630.
7. Minoguchi K, Tazaki T, Yokoe T, et al. Elevated production of tumor necrosis factor-A by monocytes in patients with obstructive sleep apnea syndrome. Chest 2004; 126: 1473-1479.
8. Muraki I, Tanigawa T, Yamagishi K, et al. Nocturnal intermittent hypoxia and C reactive protein among middleaged community residents: A cross-sectional survey. Thorax 2010; 65: 523-527.
9. Bixler EO, Vgontzas AN, Ten Have T, et al. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998; 157: 144-148.
10. Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol 2005; 99: 1592-1599.
11. Sahlman J, Miettinen K, Peuhkurinen K, et al. The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea. J Sleep Res 2010; 19: 341-348.
12. Alberti A, Sarchielli P, Gallinella E, et al. Plasma cytokine levels in patients with obstructive sleep apnea syndrome: A preliminary study. J Sleep Res 2003; 12: 305-311.
13. Punjabi NM, Sorkin JD, Katzel LI, et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002; 165: 677-682.
14. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008; 5: 136-143.
15. Svensson M, Venge P, Janson C, et al. Relationship between sleep-disordered breathing and markers of systemic inflammation in women from the general population. J Sleep Res 2012; 21: 147-154.
16. Theorell-Haglow J, Berne C, Janson C, et al. Obstructive sleep apnoea is associated with decreased insulin sensitivity in females. Eur Respir J 2008; 31: 1054-1060.
17. Sasanabe R, Banno K, Otake K, et al. Metabolic syndrome in Japanese patients with obstructive sleep apnea syndrome. Hypertens Res 2006; 29: 315-322.
18. Ip MS, Lam B, Ng MM, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670-676.
19. Hall MH, Okun ML, Sowers M, et al. Sleep is associated with the metabolic syndrome in a multi-ethnic cohort of midlife women: The SWAN Sleep Study. Sleep 2012; 35: 783-790.
20. Bonsignore MR, McNicholas WT, Montserrat JM, et al. Adipose tissue in obesity and obstructive sleep apnoea. Eur Respir J 2012; 39: 746-767.
21. Kohler M, Ayers L, Pepperell JC, et al. Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: A randomised controlled trial. Thorax 2009; 64: 67-73.
22. Arias MA, Garća-Ŕo F, Alonso-Fernández A, et al. CPAP decreases plasma levels of soluble tumour necrosis factor-A receptorr in obstructive sleep apnoea. Eur Respir J 2008; 32: 1009-1015.
23. West SD, Nicoll DJ, Wallace TM, et al. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and typee diabetes. Thorax 2007; 62: 969-974.
24. Sharma SK, Agrawal S, Damodaran D, et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med 2011; 365: 2277-2286.
25. Hoyos CM, Killick R, Yee BJ, et al. Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea: A randomised sham-controlled study. Thorax 2012; 67: 1081-1089.
26. Coughlin SR, Mawdsley L, Mugarza JA, et al. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 2007; 29: 720-727.
27. Weinstock TG, Wang X, Rueschman M, et al. A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep 2012; 35: 617B-625B.
28. Lam JC, Lam B, Yao TJ, et al. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur Respir J 2010; 35: 138-145.
29. Kritikou I, Basta M, Tappouni R, et al. Sleep apnoea and visceral adiposity in middle-aged male and female subjects. Eur Respir J 2013; 41: 601-609.
30. Vgontzas AN, Zoumakis E, Bixler EO, et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 2004; 89: 2119-2126.
31. Orio F Jr, Palomba S, Cascella T, et al. Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: Results of a 6-month study. J Clin Endocrinol Metab 2005; 90: 6072-6076.
32. Bonsignore MR, Esquinas C, Barceló A, et al. Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea. Eur Respir J 2012; 39: 1136-1143.
33. Greenberg-Dotan S, Reuveni H, Simon-Tuval T, et al. Gender differences in morbidity and health care utilization among adult obstructive sleep apnea patients. Sleep 2007; 30: 1173-1180.
34. Lavie-Nevo K, Pillar G. Evening-morning differences in blood pressure in sleep apnea syndrome: Effect of gender. Am J Hypertens 2006; 19: 1064-1069.
35. Redline S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apnea-hypopnea and incident stroke: The sleep heart health study. Am J Respir Crit Care Med 2010; 182: 269-277.
36. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-1384.
37. Bixler EO, Vgontzas AN, Lin HM, et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000; 160: 2289-2295.
38. Kapsimalis F, Kryger MH. Gender and obstructive sleep apnea syndrome, part 1: Clinical features. Sleep 2002; 25: 412-419.
39. Kritikou I, Vgontzas AN, Fernandez-Mendoza J, et al. Determinants of objective vs. subjective sleepiness in healthy controls and apneic research volunteers: The role of depression, abdominal obesity, and sleep duration. Sleep 2012; 35: A271.
40. Basta M, Lin HM, Pejovic S, et al. Lack of regular exercise, depression, and degree of apnea are predictors of excessive daytime sleepiness in patients with sleep apnea: Sex differences. J Clin Sleep Med 2008; 4: 19-25.
41. Borel JC, Tamisier R, Gonzalez-Bermejo J, et al. Noninvasive ventilation in mild obesity hypoventilation syndrome: A randomized controlled trial. Chest 2012; 141: 692-702.
42. Sivam S, Phillips CL, Trenell MI, et al. Effects off weeks of continuous positive airway pressure on abdominal adiposity in obstructive sleep apnoea. Eur Respir J 2012; 40: 913-918.
43. Matthaei S, Stumvoll M, Kellerer M, et al. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev 2000; 21: 585-618.
44. Phillips CL, Yee BJ, Trenell MI, et al. Changes in regional adiposity and cardio-metabolic function following a weight loss program with sibutramine in obese men with obstructive sleep apnea. J Clin Sleep Med 2009; 5: 416-421.
45. Totsikas C, Rohm J, Kantartzis K, et al. Cardiorespiratory fitness determines the reduction in blood pressure and insulin resistance during lifestyle intervention. J Hypertens 2011; 29: 1220-1227.
46. Foster GD, Borradaile KE, Sanders MH, et al. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with typee diabetes: The Sleep AHEAD study. Arch Intern Med 2009; 169: 1619-1626.